Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

HAVAS Q1 Revenue Increases - Quick Facts

HAVAS (HAVSF.PK) said its revenue for the first quarter rose 7.2% to 387 million euros from 361 million euros in the year-ago quarter. Growth at constant exchange rates was 5.3%.

David Jones, Global CEO Havas, stated, "The Group achieved good growth in the first quarter of 2012, despite a high comparative benchmark. A particular highlight was the strong performance in France given what remains an uncertain economic environment in Europe. North America continued its performance in line with the 4(th) quarter of 2011 and the very strong growth in the emerging markets was maintained with double digit growth in Asia Pacific and Latin America. All disciplines contributed to our performance including a continued acceleration in digital. These results are an endorsement of the relevance of our business model, based on putting digital at the core of all our activities."

Click here to receive FREE breaking news email alerts for Havas SA and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.